JPWO2023277168A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2023277168A5
JPWO2023277168A5 JP2023532082A JP2023532082A JPWO2023277168A5 JP WO2023277168 A5 JPWO2023277168 A5 JP WO2023277168A5 JP 2023532082 A JP2023532082 A JP 2023532082A JP 2023532082 A JP2023532082 A JP 2023532082A JP WO2023277168 A5 JPWO2023277168 A5 JP WO2023277168A5
Authority
JP
Japan
Prior art keywords
polynucleotide
nucleotides
modified
sugar
nucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023532082A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023277168A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/026411 external-priority patent/WO2023277168A1/ja
Publication of JPWO2023277168A1 publication Critical patent/JPWO2023277168A1/ja
Publication of JPWO2023277168A5 publication Critical patent/JPWO2023277168A5/ja
Pending legal-status Critical Current

Links

JP2023532082A 2021-06-30 2022-06-30 Pending JPWO2023277168A1 (https=)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021109239 2021-06-30
JP2021169846 2021-10-15
PCT/JP2022/026411 WO2023277168A1 (ja) 2021-06-30 2022-06-30 ポリヌクレオチド及び医薬組成物

Publications (2)

Publication Number Publication Date
JPWO2023277168A1 JPWO2023277168A1 (https=) 2023-01-05
JPWO2023277168A5 true JPWO2023277168A5 (https=) 2025-07-02

Family

ID=84692765

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023532082A Pending JPWO2023277168A1 (https=) 2021-06-30 2022-06-30

Country Status (7)

Country Link
US (1) US20240325426A1 (https=)
EP (1) EP4365288A4 (https=)
JP (1) JPWO2023277168A1 (https=)
KR (1) KR20240026181A (https=)
AU (1) AU2022302611A1 (https=)
CA (1) CA3225964A1 (https=)
WO (1) WO2023277168A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024185697A1 (ja) * 2023-03-03 2024-09-12 国立大学法人東海国立大学機構 ポリヌクレオチド連結産物の製造方法
WO2025111430A1 (en) * 2023-11-21 2025-05-30 Prime Medicine, Inc. CHEMICAL MODIFICATIONS IN mRNA POLY(A) TAIL
WO2026010855A1 (en) * 2024-07-02 2026-01-08 Trilink Biotechnologies, Llc Modified rna for increasing protein expression

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01114346A (ja) 1987-10-26 1989-05-08 Seiko Electronic Components Ltd 冷却ファン付モータ
US20030083272A1 (en) * 1997-09-19 2003-05-01 Lahive & Cockfield, Llp Sense mrna therapy
CA2723265C (en) * 2008-05-02 2015-11-24 Epicentre Technologies Corporation Selective 5' ligation tagging of rna
EP3460064B8 (en) * 2011-04-03 2024-03-20 The General Hospital Corporation d/b/a Massachusetts General Hospital Efficient protein expression in vivo using modified rna (mod-rna)
JP5678022B2 (ja) 2012-10-31 2015-02-25 京セラドキュメントソリューションズ株式会社 画像形成装置及び画像形成プログラム
AU2013374345A1 (en) * 2013-01-17 2015-08-06 Moderna Therapeutics, Inc. Signal-sensor polynucleotides for the alteration of cellular phenotypes
CA2955375A1 (en) 2014-07-17 2016-01-21 Modernatx, Inc. Terminal modifications of polynucleotides
JP6275576B2 (ja) 2014-07-24 2018-02-07 ヤンマー株式会社 作業車輌
US20180085391A1 (en) 2014-08-08 2018-03-29 Modernatx, Inc. Compositions and methods for the treatment of ophthalmic diseases and conditions
EP3233132A4 (en) * 2014-12-19 2018-06-27 Modernatx, Inc. Terminal modifications of polynucleotides
KR102789862B1 (ko) 2016-01-11 2025-04-03 인네이트 튜머 이뮤니티, 인코포레이티드 Sting 활성과 연관된 상태 예컨대 암의 치료를 위한 시클릭 디뉴클레오티드
EP4082579A4 (en) * 2019-12-26 2024-06-26 National University Corporation Tokai National Higher Education and Research System POLYNUCLEOTIDE AND MEDICINAL COMPOSITION

Similar Documents

Publication Publication Date Title
JPWO2023277168A5 (https=)
RU2017114156A (ru) N-ацетилгалактозаминовые (galnac) фосфорамитиды, их конъюгаты с нуклеиновыми кислотами и их применение
JP6284977B2 (ja) 2’−o−修飾rna
KR20240028502A (ko) 핵산 리간드 및 이의 접합체, 및 이를 위한 제조 방법 및 이의 용도
JP2023113843A5 (https=)
JP2022519019A5 (https=)
JP2019522972A5 (https=)
JP2016523087A5 (https=)
JP2015518714A5 (https=)
JP2010538677A5 (https=)
WO2020238766A1 (zh) 核酸、药物组合物与缀合物及制备方法和用途
JP2026016798A (ja) オリゴヌクレオチド組成物及びその作製方法
JPWO2023106310A5 (https=)
JP2021505129A5 (https=)
WO2018177825A1 (en) Orthogonal protecting groups for the preparation of stereodefined phosphorothioate oligonucleotides
JP2019213567A (ja) ヘアピン型一本鎖rna分子の製造方法
WO2020233680A1 (zh) 核酸、药物组合物与缀合物及制备方法和用途
JPWO2021070494A5 (https=)
US20230220386A1 (en) Sirna conjugate, double-stranded sirna conjugate, salt thereof and application thereof
AU2023231320A1 (en) Application of tetracyclic compound in treatment of tumors
JPH09510206A (ja) オリゴヌクレオチドの合成に用いる組成物および方法
JP2000512630A (ja) 2’―置換ヌクレオシドおよびオリゴヌクレオチド誘導体
CA2179987C (en) Monohydrate of (e)-2'-deoxy-2'-(fluoromethylene)cytidine
US8680262B2 (en) Purification of oligonucleotides
ES3062040T3 (en) Glycoside compound, amidite compound, and production method for polynucleotide using said compounds